Material and Methods
Malaria suppression. The study of the value of malaria suppression in the treatment of this syndrome comprised 18 children, all of whom had initially received a course of prednisone in a dosage of 2 mg./kg. body weight for a period of 28 days without remission of proteinuria. These cases were then divided into two comparable groups of 9 cases each, and malaria prophylaxis was given to one group only. Both groups, however, continued with steroids for a similar time, i.e. 12-24 months (Table I ). The dosage schedule used was the same as above, but medication was given only on the first 3 days of each week, and a maximum of 80 mg. prednisone a day was not exceeded in a single child.
Case matching was done on the basis of age, sex, and severity of glomerular histological change (Table I) . Received March 29, 1968. Histological grading was similar to that used in a previous study (Kibukamusoke and Hutt, 1967) .
Immunosuppression. In the immunosuppressant study 3 of the children in the above group were included in addition to 11 others. All these had received steroids for periods ranging from 2 months to 3 years without benefit. Renal histopathology was available in 11 of these cases. 10 children showed mild or minimal proliferative lesions and the other child had more severe proliferation of glomerular endothelial cells.
In none of the cases was a specific cause of the nephrotic syndrome found, nor was there evidence of streptococcal infection in the present or immediate past. 14 of the 18 children in the malaria suppression study originally had Plasmodium malariae in their blood, as did 12 of the 14 in the group to which immunosuppressants were given.
Malaria prophylaxis study. Full response was determined in terms of total abolition of proteinuria.
Malaria prophylaxis, varying from 12-18 months, was achieved by using Camoprima Infatabs*. These are available in tablet form each containing 75 mg. amodiaquine and 15 mg. primaquine. Two tablets were given to each child once on a particular day (Sunday) each week, this combination ensuring the elimination of both the tissue and blood forms of the malaria parasite (Adams and Maegraith, 1966) .
Immunosuppressant study. Azathioprine was chosen because it is an effective immunosuppressant drug which rarely produces toxic effects if used with care (Rundles et al., 1961) . It is a derivative of 6-mercaptopurine and its side effects are predominantly on the bone-marrow where varying degrees of granulocytic depression may occur (Rundles et al., 1961; Dacie, 1962) .
The dosage was 1-5-2-5 mg./kg. body weight, and this was given on every day of the week in a single dose in the morning until proteinuria disappeared, or for 12 months. The actual amount of drug given each day was found to be approximately 50 mg. (half a tablet) for each child. Malaria Prophylaxis Study (Table I) . Of the 9 cases in the protected group, 6 obtained a complete remission of proteinuria, as compared with only 3 of the 9 in the non-protected group. Unfortunately it was impossible to study a larger group because of the high default rate and the length of time required to obtain a complete remission of proteinuria (12-24 months). The results, therefore, can be interpreted only as suggestive of benefit from malaria prophylaxis. In order to obviate this disadvantage, therefore, more convenient therapeutic regimens must be found.
Azathioprine study (Table II) . Of the 14 children, 12 responded with a total disappearance of proteinuria, usually within 8 weeks, though some children required longer treatment. The reason for the lack of response in the other 2 children was obscure, but it was thought to be related to the lower original levels of malarial antibody titres which these 2 children had, compared with the rest of the group.
Discussion
Although a small percentage of cases of idiopathic childhood nephrosis seen in Europe and North America fails to respond to steroid therapy, this group of drugs has an established place in the management of the disease. The identification of an aetiological factor (the malaria parasite) in over 90% of nephrotic children in Nigeria suggested that the tropical nephrotic syndrome might be different from the type encountered in temperate climates (Gilles and Hendrickse, 1963) . It soon became known that this was true in many tropical areas (Kibukamusoke et al., 1967) .
Using the criterion of total abolition of proteinuria as indicating a full response to steroid therapy, it was found that only a small number of nephrotic children in East and West Africa responded. This feature is now recognized as distinctive for the form of nephrotic syndrome associated with quartan malaria (Kibukamusoke et al., 1967) Owing to the relatively minor changes that are found in the glomeruli of these children, it was felt that response might be obtained with the use of some suitable drug. The finding of raised malaria antibodies in nephrotic sera (Kibukamusoke et al., 1967) and the persistence of malaria parasites in the circulation (despite this increase) raised the possibility of the damage being due to immunological reactions resulting from the deposition of immune complexes in the glomeruli. Evidence for these complexes has now been reported in the serum Complete (8 wk.)
*Cases which were also included in the original malaria prophylaxis study. Complete = total abolition of proteinuria.
The duration before response to azathioprine is given in brackets. (Soothill and Hendrickse, 1967 
